Standout Papers

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs 2005 2026 2012 2019 900
  1. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs (2005)
    Dylan Morrissey, Jennifer A. Lockridge et al. Nature Biotechnology
  2. RNA interference in the era of nucleic acid therapeutics (2024)
    Vasant Jadhav, Akshay Vaishnaw et al. Nature Biotechnology

Immediate Impact

15 by Nobel laureates 29 from Science/Nature 131 standout
Sub-graph 1 of 16

Citing Papers

Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
168 intermediate papers

Works of Vasant Jadhav being referenced

Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth
2016
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
2005 Standout
and 12 more

Author Peers

Author Last Decade Papers Cites
Vasant Jadhav 2112 562 147 282 35 2.4k
Chandra Vargeese 2174 464 178 278 29 2.5k
Daniela Castanotto 2656 614 145 428 44 3.0k
Raman Bahal 2781 901 88 226 62 3.3k
Donald J. Davidson 1318 644 127 152 35 1.9k
Xinlin Du 2569 726 110 115 20 3.1k
Glenn M. Swartz 965 530 184 241 40 2.0k
K.C. Ingham 1004 376 45 149 42 2.1k
Anne M. Noronha 1630 375 105 136 49 1.9k
Troels Koch 2899 666 74 120 72 3.3k
Klaus Charissé 3330 601 86 227 55 3.8k

All Works

Loading papers...

Rankless by CCL
2026